MBIO MBIO
Company Profile ↓Company Overview
MBIO (MBIO) is a publicly traded company listed on with a market capitalization of $4.38M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.00.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -60.47% |
| 6 Months: | -23.38% |
| 3 Months: | -22.88% |
| 1 Month: | -15.93% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.87 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 68.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 50.00K | 0 | 0 | -50.00K | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 253.00K | 885.00K | 624.00K | 670.00K | 1.06M |
| Operating Income | -537.00K | -658.00K | -843.00K | -822.00K | -1.04M | -1.67M | -7.83M | -3.31M | -5.67M | -7.08M | -15.73M | -6.48M | -5.24M | -7.66M | -11.85M | -9.75M | -10.21M | -10.00M | -15.92M | -11.52M | -14.12M | -10.43M | -15.09M | -14.44M | -17.08M | -19.64M | -18.24M | -18.85M | -16.32M | -13.89M | -10.31M | -5.23M | -8.54M | -1.46M | - | -253.00K | -885.00K | -624.00K | -670.00K | -1.06M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -212.00K | -885.00K | -624.00K | -670.00K | -1.06M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00K | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -153.00K | -762.00K | -468.00K | -538.00K | -955.00K |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -579.00K | -716.00K | -911.00K | -903.00K | -1.13M | -1.87M | -8.75M | -3.22M | -5.53M | -6.94M | -15.60M | -6.28M | -5.09M | -7.52M | -11.77M | -9.61M | -10.40M | -10.17M | -16.21M | -11.86M | -14.60M | -12.95M | -14.96M | -14.36M | -17.00M | -19.80M | -19.10M | -19.00M | -16.69M | -16.23M | -10.06M | -5.19M | -8.20M | -1.41M | - | -153.00K | -762.00K | -468.00K | -538.00K | -955.00K |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.19 | -0.16 | -0.19 | -2.71 | -2.50 | -2.42 | -2.06 | -2.00 | -1.23 | -24.81 | -18.36 | -1.96 | - | -0.05 | -0.19 | -0.07 | - | -0.14 |
| R&D Expense | - | 500.00K | - | 500.00K | 500.00K | 500.00K | - | 500.00K | 500.00K | 500.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -11.36M | -31.79M | -31.22M | -45.88M | -56.81M | -66.72M | -76.16M | -49.26M | -16.25M | -2.43M |
| Net Income | -12.65M | -31.29M | -30.66M | -46.39M | -60.02M | -66.37M | -77.53M | -51.60M | -15.75M | -1.92M |
| Diluted EPS | - | - | - | - | - | -0.76 | -10.09 | -299.95 | -38.57 | -0.39 |
| R&D Expense | 2.00M | 100.00K | 2.10M | - | - | - | - | - | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 0 | 27.50M | 63.49M | 42.75M | 73.44M | 109.90M | - | 92.42M | 17.74M | 9.31M | 17.59M |
| Current Assets | - | - | - | - | - | - | - | 78.85M | 11.35M | 8.61M | 17.59M |
| Cash & Equivalents | - | - | - | 16.47M | 61.41M | 97.80M | - | 75.66M | 6.23M | 6.84M | 17.27M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | 299.00K | 3.88M | 402.00K | 217.00K |
| Total Liabilities | 4.13M | 3.22M | 3.66M | 6.36M | 21.79M | 11.46M | - | 46.15M | 17.62M | 13.18M | 8.06M |
| Current Liabilities | 4.13M | 3.22M | 3.61M | 5.62M | 7.77M | 9.52M | - | 15.11M | 15.37M | 12.61M | 7.91M |
| Long Term Debt | - | - | - | - | - | - | - | 27.44M | - | - | - |
| Total Debt | - | - | - | - | - | - | - | 31.38M | 2.50M | 878.00K | 0 |
| Total Equity | -4.13M | 24.28M | 59.83M | 36.40M | 51.65M | 98.44M | - | 46.27M | 123.00K | -3.87M | 9.53M |
| Shares Outstanding | - | - | - | - | - | - | - | 198.36K | 1.01M | 1.83M | 7.30M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.13M | -12.95M | -19.24M | -33.58M | -37.32M | -53.67M | -65.07M | -49.48M | -11.41M | -5.26M |
| Investing Cash Flow | 0 | -29.05M | 557.00K | 13.91M | -4.41M | -5.37M | -2.95M | 5.89M | 0 | 1.17M |
| Financing Cash Flow | 31.63M | 49.98M | 181.00K | 65.12M | 78.12M | 70.85M | 34.06M | -26.08M | 11.27M | 14.53M |
| Capital Expenditure | - | -424.00K | -6.87M | -2.35M | -1.93M | -3.99M | -2.71M | -64.00K | -0 | - |
| Free Cash Flow | - | -13.37M | -26.11M | -35.93M | -39.24M | -57.65M | -67.78M | -49.54M | -11.41M | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| ROE % | -52.1% | -52.3% | -84.2% | -89.8% | -61.0% | - | -167.5% | -41,952.8% | 406.7% | -20.2% |
| ROCE % | -46.8% | -53.1% | -84.1% | -69.9% | -56.6% | - | -98.5% | -2,077.6% | 492.1% | -25.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MBIO
MBIO Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE1DbFU3Z0o4c1NDbjZscWljcFJ6VUFJTjVickx1NkNxZlF3OE1WbHF1ZGpnTWFudGRrMl9sNlVZZGI2SWxUS2plTVpWT21UTzZkRzd1OXRvU0ZRS0l3RUE?oc=5" target="_blank">MBIO Should I Buy</a> <font c…
Mustang Bio Inc (MBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9qMTJXYWVfenVUaEtwYzdNUFp0V3Z6Q3Nod2ZnQkhYSzRORFZ4U1FJa0NUaUFBcjJfeGJwdmJuUzZ4X0xwbTdsWjczbjVwek1aZ3gtRmwwdnFOQllpOVNHS01lTDlFVWs5ZjJ6c243ZkIwUQ?oc=5" target="_blank">Mustang Bio I…
Mustang Bio (MBIO) Proxy Filing Summary - Quartr
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9tVkhqWDlLUkkwS2s3MUhzejhfTTRheFV6NnVHOGVfRjdfcUN0cmFyd25qOWdwbGRSbmRPQTJRbk1udUJXNlQ4Vl81ZWNpbFVTa1JUdmJsOGc1Z29SMWN4Zzlia1RDQ2lfekQyY3RQQk5HMDR3QUMw?oc=5" target="_blank">Mustang…
Traders are paying attention to the gapping stocks in Friday's session. - ChartMill
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQclRPVmN2RUJpSUNFaXpwdkJtZXlBaXgwX29PV1ZYVUp6MWg4bVRwS0hOMFp1dmw2YXYyTnpDb3dwVmZvS29fVkZzUFhVaWVFSWRsaXItSnNoM1ZvYkpDazFNdlZoSHJGd01rc2tuVUE1VGpmdTlGOVlaTU1wdlNCcWF4VjAtanBKaEpzMW…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE45OHlIX1hXTmU0UXBWVktiRGlsRlJ6emVuc2RlTzA0akN3aHRTWW1yVDdoOWI3TndlMjdERW9YUS15Z1h1eGE1ZXZQWlIzTkMt?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Mustang Bio (MBIO) Slips Slightly as Stock Hovers Near Key Support Zone - Head and Shoulders - dars.gov.et
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPdmtXYWF5VklMV09VMWgyTGNOQ2ZiVDVRdExuREpIS21MXzN0c1hXSWNSTTAyNXJKMk1oRTVGTmJQSE5WQVZyaFc0TjhnanpiUUc1eHVCbUUxd2RuVW1FZ19scmQycHdoSU5jdnVTU1lwRThiTHVQQVVCZnVWckN6NFNhanRCbXRmUmxlYm…
MBIO — Frequently Asked Questions
What is the current share price of MBIO?
As of 2026-08-05 17:25 PDT, MBIO trades at $0.60 on NASDAQ/NYSE. Its 52-week range is $0.56 to $1.87.
What is the market capitalisation of MBIO?
MBIO has a market capitalisation of $4.38M on NASDAQ/NYSE.
What is the P/E ratio of MBIO?
MBIO trades at a trailing price-to-earnings (P/E) ratio of -1.54. Its price-to-book (P/B) ratio is 0.46.
What is the return on equity (ROE) of MBIO?
MBIO has a return on equity (ROE) of -20.16%. Its return on capital employed (ROCE) is -25.13%.
Is MBIO a good stock to buy?
This page provides a data-driven analysis of MBIO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.